Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DexCom, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
DXCM
Nasdaq
3841
www.dexcom.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DexCom, Inc.
Advancing type 1 diabetes care during pregnancy: a Canadian first
- Nov 9th, 2026 7:00 am
What Is Behind The Move In DexCom Stock?
- Nov 7th, 2026 5:49 am
He went from washing lab equipment for $10 an hour to leading a $30 billion healthcare company. His advice to Gen Z: Raise your hand
- Nov 7th, 2026 2:00 am
Guardant Health (GH) Could Be 17% Undervalued As Board Appointment Tests Valuation
- Nov 4th, 2026 10:19 pm
Will Shield Award Recognition Change Guardant Health Stock Narrative
- Nov 4th, 2026 9:41 pm
Kevin Sayer Joins Guardant Health Board of Directors
- Nov 3rd, 2026 2:30 pm
DexCom to Launch 15-Day G7 CGM System in Canada This November
- Nov 3rd, 2026 8:59 am
Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI Diagnostics
- Nov 3rd, 2026 7:41 am
3 quality compounders with promising prospects
- Nov 3rd, 2026 4:17 am
Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion
- Nov 2nd, 2026 9:35 am
Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign
- Nov 2nd, 2026 6:00 am
Dexcom lifts 2026 revenue outlook after positive Q3
- Nov 2nd, 2026 5:24 am
DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectory
- Oct 31st, 2026 8:43 pm
DexCom (DXCM) Stock Looks Below Fair Value on Cash Flow
- Oct 31st, 2026 4:13 am
DexCom (DXCM) Brings Its 15 Day Glucose Monitor To Canada
- Oct 31st, 2026 12:15 am
Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes Off
- Oct 30th, 2026 2:32 pm
DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says
- Oct 30th, 2026 9:53 am
Dexcom (DXCM) Q3 2026 Earnings Call Transcript
- Oct 30th, 2026 8:29 am
DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
- Oct 30th, 2026 8:00 am
DexCom, Inc. Q3 2026 Earnings Call Summary
- Oct 30th, 2026 6:30 am
Scroll